docProstate Cancer Program RIP - UCSF Helen Diller Family
download 
Report Transcription
Prostate Cancer Program RIP - UCSF Helen Diller Family
SAVE-‐THE-‐DATES! Prostate Cancer Program Research In Progress (RIP) Series Effective: 9/24/14 Recurrence/Day: 2nd and 4th Wednesdays of every month Time: 9am to 10am Place: Mission Bay Campus, Mission Hall, Room MH-‐6500 (6th Flr Large Conference Room) Date Name 24-‐Sep Robert Blelloch, MD, PhD 8-‐Oct Mack Roach III, MD, FACR 2014 29-‐Oct Fred Schaufele, PhD Topic Serum microRNAs as prognostics in prostate cancer RTOG 9413: Long Term Results of a Phase III Randomized Trial and the Immunological Implications Drug Screens that Target the Androgen Receptor in Castration-‐Resistant Prostate Cancer (moved from 22-‐Oct) 12-‐Nov Eric Small, MD 26-‐Nov no meeting, week of Thanksgiving 10-‐Dec Quarterly Program Research Meeting Neuroendocrine Prostate Cancer in the SU2C West Coast Dream Team AR Signaling and Mechanisms of Resistance (9am-‐12pm / Helen Diller, Room HD160, Mission Bay) 24-‐Dec no meeting, Winter Holiday 2015 14-‐Jan 28-‐Jan 11-‐Feb 25-‐Feb 11-‐Mar 25-‐Mar 8-‐Apr 22-‐Apr 13-‐May 27-‐May 10-‐Jun 24-‐Jun Lawrence Fong, MD Susan Noworolski, PhD June Chan, ScD no meeting, GU ASCO Rahul Aggarwal, MD Immunotherapy of GU Malignancies Multiparametric MR Imaging to Assess Risk of Progression of Prostate Cancer Translational studies in nutrition, exercise, and prostate cancer survivorship Developing Therapeutic and Imaging Targets in Aggressive Phenotype Metastatic Castration Resistant Prostate Cancer Quarterly Program Research Meeting CANCELLED Charles Ryan, MD, Fred Schaufele, PhD, Jesse Cortez, PhD AR targeting strategy development (chalk talk) Terence Friedlander, MD Circulating tumor cells in prostate cancer Albert Chang, MD and John Kurhanewicz, PhD TBD Matthew Cooperberg, MD, MPH TBD Quarterly Program Research Meeting (8am-‐12pm) TBD Michael Evans, PhD New radiotracer development to measure oncogene signaling in prostate cancer with PET TO SIGN UP: Please contact Linda Eng -‐ [email protected]